Gilead Must Post $14M To Keep Ban On Generic Lexiscan | McDermott

COVERAGE

Gilead Must Post $14M To Keep Ban On Generic Lexiscan

October 31, 2022

Read time: 2 min

Paul Hughes is quoted in this Law360 article in which Paul, alongside Ian Brooks and Jason Leonard represented Astellas Pharma.

Read Full Article

Paul W. Hughes

Partner

Washington, DC

Ian B. Brooks

Partner

Washington, DC

Jason Leonard

Partner

New York – One Vanderbilt Avenue

You may also like

Litigation & Dispute Resolution Intellectual Property Patent Litigation United States

Media Contact

publicrelations@mcdermottlaw.com